7Baggers
 published on: 2025-11-01 11:59:10  newser.com Sat, 01 Nov 2025 16:59:10 GMT
 published on: 2025-10-31 05:52:18  newser.com Fri, 31 Oct 2025 10:52:18 GMT
 athira pharma announces 10-for-1 reverse stock split  MSN Sun, 26 Oct 2025 00:09:12 GMT
 published on: 2025-10-18 13:43:56  newser.com Sat, 18 Oct 2025 18:43:56 GMT
 athira pharma (nasdaq:atha) shares down 0.8% – here’s why  Defense World Thu, 16 Oct 2025 06:18:24 GMT

Athira Pharma, Inc
(NASDAQ:ATHA) 

ATHA stock logo

Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and stop neurodegradation. Its lead product candidate is ATH-1017, a blood brain barrier-penetrating, small hepatocyte growth factor/MET activator that is in LIFT-AD...

Founded: 2011
CEO: Leen Kawas  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends